SineuGene Therapeutics

Private

BeijingHealthcare & Life Scienceshttps://sineugene.com/

Last Round

VC Round

Aug 1, 2024

Company Overview

SineuGene Therapeutics is a biopharmaceutical company that develops innovative gene therapy treatments for neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyadeno-associated virusAAVantisense oligonucleotideASOneurodegenerative diseasebiotechALS treatmentgene delivery platformclinical-stage biotechdrug discoveryprecision medicinegenetic medicinebiopharmaclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SineuGene Therapeutics Comps

Public and private peers based on sector, stage, and business model.

SineuGene Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SineuGene Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Aug 1, 2024
Angel	Jan 18, 2023
Seed	Mar 1, 2022

View all Funding Rounds

SineuGene Therapeutics Investors

Notable investors and investment history

SineuGene Therapeutics investors
Investor	Rounds
MSA Capital	Angel
ZGC Capital	VC Round
Transfar Capital	VC Round
ZBJL Capital	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 3, 2026
Monthly visitors increased 44% MoM.
Aug 1, 2024
$14M round led by ZGC Capital.

View all signals

SineuGene Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SineuGene Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SineuGene Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range2

Year Founded2021

Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.